Researchers from Seoul National University Medical Center have found that breast cancers detected by ultrasound only are not very sensitive to computer-aided detection.
Researchers from Seoul National University Medical Center have found that breast cancers detected by ultrasound only are not very sensitive to computer-aided detection.
Dr. Sang Kyu Yang and colleagues applied CAD (ImageChecker, R2 Technologies) to 96 bilateral mammograms obtained on a full-field digital system. The patient population consisted of 26 women with 29 ultrasound-detected cancers that had all appeared normal on mammography and 70 women with 70 mammography-detected cancers. All in the latter group had negative findings at clinical exam.
The researchers scored a lesion as a true positive if the CAD system marked the correct lesion type (microcalcifications or mass) in at least one of two views. All CAD marks that were not located on the suspicious lesion were scored as false positives. They presented their findings in a poster at the 2005 RSNA meeting.
In the ultrasound-detected group, there were 17 marks on masses and five on calcifications - correctly identifying six masses. The false-positive rate was 0.15 per image and 0.62 per case.
In the mammography group, the CAD system scored 116 marks on masses and 185 on calcifications, resulting in 58 and 139 true positives, respectively. The false-positive rate was 0.37 per image and 1.48 per case.
The sensitivity of CAD according to the radiologic primary features in the 29 ultrasound-detected cancers was 17.2%, broken down as follows:
The sensitivity of CAD according to the radiologic primary features in the 70 mammography-detected cancers was 95.7%, broken down as follows:
The mean tumor size of ultrasound- and mammography-detected cancers was 1 cm and 1.8 cm, respectively. Dense breasts were more common in the ultrasound-detected group (73%) than in the mammography-detected group (63%), though the difference was not statistically significant.
The researchers consided the information useful when applying CAD to screening mammography and adjunct ultrasound to detect early breast cancers.
For more information from the Diagnostic Imaging archives:
Elastography slashes biopsy rate for benign breast lesions
Study challenges value of ultrasound in breast cancer screening
Adjunctive breast imaging modalities come up short
FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection
November 20th 2024The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.
FDA Clears Updated AI Platform for Digital Breast Tomosynthesis
November 12th 2024Employing advanced deep learning convolutional neural networks, ProFound Detection Version 4.0 reportedly offers a 50 percent improvement in detecting cancer in dense breasts in comparison to the previous version of the software.